ACH
Accendra Health, Inc. (ACH) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
High net debt and sub-1.0 interest coverage leave ACH more exposed to fertilizer price or volume swings than peers with stronger balance sheets, constraining earnings resilience.
Current and quick ratios below 0.5 indicate tight near-term liquidity, so working-capital shocks or refinancing stress could pressure ACH more than better-capitalized peers.
Negative debt-to-equity reflects a leveraged capital structure, which amplifies downside if ammonia or potash spreads weaken versus peers with lower fixed financial obligations.
Dependence on favorable payables timing and a negative cash conversion cycle can reverse quickly, making cash generation less predictable than peers with longer liquidity buffers.
Opportunities
Very high payables days and a negative cash conversion cycle support cash retention, giving ACH more working-capital efficiency than peers with shorter supplier terms.
If nitrogen and potash pricing remains firm, ACH’s leveraged operating model can translate incremental margin gains into faster earnings recovery than less operationally geared peers.
Tight inventory and receivables management reduces cash tied up in operations, improving liquidity conversion relative to peers with heavier seasonal working-capital needs.
Overall Score
ACH’s forward positioning is supported by strong working-capital efficiency and operating leverage, but elevated leverage and weak liquidity keep financial risk meaningfully higher than peers.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Accendra Health, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
